文献速递儿童青少年精神睡眠障碍

Gabra2-1 突变小鼠表型模拟 ARHGEF9 智力障碍综合征

Human ARHGEF9 intellectual disability syndrome is phenocopied by a mutation that disrupts collybistin binding to the GABAA receptor α2 subunit.
PubMed 文献 · Mol Psychiatry · 2022-02-15

ARHGEF9 突变可导致智力障碍,其编码的 collybistin(Cb)调节抑制性突触。对 41 例 ARHGEF9 患者报告的分析显示智力障碍普遍存在,并常见癫痫、脑电异常、行为症状和睡眠障碍。研究者将 GABAA 受体 α2 亚基的 Cb 结合基序替换为 α1 亚基的 gephyrin 结合基序(Gabra2-1),该突变导致 Cb 表达下调,Gabra2-1 小鼠表现出工作与识别记忆缺陷、多动、焦虑、社交偏好降低和自发性癫痫,重现了患者特征,并提示含 α2 亚基的 GABAA 受体是可药物开发的靶点。

要点

  • 41 例 ARHGEF9 患者报告中智力障碍普遍存在,并常见癫痫、脑电异常、行为症状和睡眠障碍。
  • Gabra2-1 突变使 Cb 表达强烈下调,尤其在胆囊收缩素篮状细胞抑制性突触处。
  • Gabra2-1 小鼠重现 ARHGEF9 患者的多项特征,并提示含 α2 亚基的 GABAA 受体是可药物开发的靶点。

核心结论

  • Gabra2-1 小鼠表型模拟人类 ARHGEF9 突变的多个特征,并揭示含 α2 亚基的 GABAA 受体是该复杂智力障碍综合征的可药物开发靶点。

研究设计与样本

  • 研究对 41 例 ARHGEF9 患者报告进行汇总评估,并构建了将 α2 亚基大胞内环中 Cb 结合基序替换为 α1 亚基 gephyrin 结合基序的 Gabra2-1 突变小鼠。

主要发现

  • 41 例 ARHGEF9 患者报告中智力障碍普遍存在,其他常报告的症状包括癫痫、基线脑电活动异常、行为症状和睡眠障碍。
  • Gabra2-1 突变导致 Cb 表达强烈下调,尤其在胆囊收缩素篮状细胞抑制性突触处。
  • Gabra2-1 小鼠存在工作记忆和识别记忆缺陷,以及多动、焦虑和社交偏好降低。
  • Gabra2-1 小鼠在出生后发育期间出现自发性癫痫,可导致死亡,并出现脑电低频波段的基线异常。
  • Gabra2-1 小鼠的脑电异常具有觉醒状态特异性,并表现为睡眠障碍,包括觉醒时间增加和在无光作为授时因子时自由运行节律丧失。

临床怎么用

  • 原文结论指出含 α2 亚基的 GABAA 受体是治疗该复杂智力障碍综合征的可药物开发靶点。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Intellectual disability (ID) is a common neurodevelopmental disorder that can arise from genetic mutations ranging from trisomy to single nucleotide polymorphism. Mutations in a growing number of single genes have been identified as causative in ID, including ARHGEF9. Evaluation of 41 ARHGEF9 patient reports shows ubiquitous inclusion of ID, along with other frequently reported symptoms of epilepsy, abnormal baseline EEG activity, behavioral symptoms, and sleep disturbances. ARHGEF9 codes for the Cdc42 Guanine Nucleotide Exchange Factor 9 collybistin (Cb), a known regulator of inhibitory synapse function via direct interaction with the adhesion molecule neuroligin-2 and the α2 subunit of GABAA receptors. We mutate the Cb binding motif within the large intracellular loop of α2 replacing it with the binding motif for gephyrin from the α1 subunit (Gabra2-1). The Gabra2-1 mutation causes a strong downregulation of Cb expression, particularly at cholecystokinin basket cell inhibitory synapses. Gabra2-1 mice have deficits in working and recognition memory, as well as hyperactivity, anxiety, and reduced social preference, recapitulating the frequently reported features of ARHGEF9 patients. Gabra2-1 mice also have spontaneous seizures during postnatal development which can lead to mortality, and baseline abnormalities in low-frequency wavelengths of the EEG. EEG abnormalities are vigilance state-specific and manifest as sleep disturbance including increased time in wake and a loss of free-running rhythmicity in the absence of light as zeitgeber. Gabra2-1 mice phenocopy multiple features of human ARHGEF9 mutation, and reveal α2 subunit-containing GABAA receptors as a druggable target for treatment of this complex ID syndrome.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Hines DJ, Contreras A, Garcia B, et al. Human ARHGEF9 intellectual disability syndrome is phenocopied by a mutation that disrupts collybistin binding to the GABAA receptor α2 subunit. Mol Psychiatry. 2022. PMID: 35169261. doi:10.1038/s41380-022-01468-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。